Flagship Private Wealth LLC Sells 235 Shares of iShares Biotechnology ETF $IBB

Flagship Private Wealth LLC cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,151 shares of the financial services provider’s stock after selling 235 shares during the period. Flagship Private Wealth LLC’s holdings in iShares Biotechnology ETF were worth $399,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of IBB. Ramirez Asset Management Inc. bought a new stake in shares of iShares Biotechnology ETF during the first quarter valued at approximately $26,000. Financial Gravity Asset Management Inc. bought a new stake in iShares Biotechnology ETF in the first quarter valued at $30,000. Woodside Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the first quarter valued at $31,000. CX Institutional bought a new stake in iShares Biotechnology ETF in the first quarter valued at $32,000. Finally, Garde Capital Inc. bought a new stake in iShares Biotechnology ETF in the first quarter valued at $36,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.7%

Shares of NASDAQ:IBB opened at $149.62 on Friday. The business’s fifty day moving average price is $138.88 and its two-hundred day moving average price is $129.89. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.04.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.